PFS was borderline significant for the presence of lytic lesion(s) (HR 1.08, 95% CI 0.99, 1.18) and for patients with serum calcium >12 mg/dL (HR 1.19, 95% CI 0.97, 1.47).
← all excerpts
Disease and outcome disparities in multiple myeloma: exploring the role of race/ethnicity in the Cooperative Group clinical trials.
1
—
—